loperamide and buprenorphine

loperamide has been researched along with buprenorphine in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (10.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (10.00)	29.6817
2010's	4 (40.00)	24.3611
2020's	4 (40.00)	2.80

Authors

Authors	Studies
Colpaert, FC	1
Iwamura, T; Tokuyama, S; Ueda, H; Yoshida, A	1
Krieg, B	1
Heller, NM; Maher, DP; Walia, D	1
Barnett, BS; Suzuki, J; Ward, HB	1
Garlapati, V; Koola, MM; Kumari, P; Varghese, SP; Wijegunaratne, H; Yovankin, T	1
Allgaier, JT; Brar, JK; Broyan, VR; Nye, L; Saxon, AJ	1
Levine, M; Lovecchio, F	1
Badea, A; Cervinski, MA; Geno, KA; Hubbard, JA; Jannetto, P; Lynch, KL; Nerenz, RD	1
Haigney, MCP; Kao, DP; Kleiman, RB; Klein, M; Krantz, MJ; Rudo, TJ; Stockbridge, N	1

Reviews

2 review(s) available for loperamide and buprenorphine

Article	Year
Discriminative stimulus properties of narcotic analgesic drugs. Pharmacology, biochemistry, and behavior, 1978, Volume: 9, Issue:6 Topics: Adrenocorticotropic Hormone; Analgesics, Opioid; Buprenorphine; Cues; Discrimination, Psychological; Drug Tolerance; Generalization, Psychological; Humans; Loperamide; Naloxone; Neurotransmitter Agents; Receptors, Opioid; Stereoisomerism; Substance-Related Disorders	1978
New Designer Drugs. Emergency medicine clinics of North America, 2021, Volume: 39, Issue:3 Topics: Analgesics, Opioid; Buprenorphine; Cannabinoids; Designer Drugs; Drug Overdose; Fentanyl; Humans; Hypnotics and Sedatives; Illicit Drugs; Loperamide; Mitragyna; Naloxone; Narcotic Antagonists; Phenethylamines; Substance-Related Disorders	2021

Article

Year

Discriminative stimulus properties of narcotic analgesic drugs.

Pharmacology, biochemistry, and behavior, 1978, Volume: 9, Issue:6

Topics: Adrenocorticotropic Hormone; Analgesics, Opioid; Buprenorphine; Cues; Discrimination, Psychological; Drug Tolerance; Generalization, Psychological; Humans; Loperamide; Naloxone; Neurotransmitter Agents; Receptors, Opioid; Stereoisomerism; Substance-Related Disorders

1978

New Designer Drugs.

Emergency medicine clinics of North America, 2021, Volume: 39, Issue:3

Topics: Analgesics, Opioid; Buprenorphine; Cannabinoids; Designer Drugs; Drug Overdose; Fentanyl; Humans; Hypnotics and Sedatives; Illicit Drugs; Loperamide; Mitragyna; Naloxone; Narcotic Antagonists; Phenethylamines; Substance-Related Disorders

2021

Other Studies

8 other study(ies) available for loperamide and buprenorphine

Article	Year
Opioid analgesic-induced apoptosis and caspase-independent cell death in human lung carcinoma A549 cells. International journal of molecular medicine, 2000, Volume: 6, Issue:3 Topics: Analgesics, Opioid; Apoptosis; Breast Neoplasms; Buprenorphine; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Caspase 1; Caspase 3; Caspases; Cell Cycle; Cell Survival; DNA Fragmentation; Female; Flow Cytometry; Humans; Loperamide; Lung Neoplasms; Molecular Structure; Stomach Neoplasms; Tumor Cells, Cultured	2000
Medizinische Monatsschrift fur Pharmazeuten, 2016, Volume: 39, Issue:11 Topics: Buprenorphine; Drug Interactions; Germany; Humans; Loperamide; Methadone; Opiate Substitution Treatment; Substance-Related Disorders; Torsades de Pointes	2016
Suppression of Human Natural Killer Cells by Different Classes of Opioids. Anesthesia and analgesia, 2019, Volume: 128, Issue:5 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Anesthesia; Buprenorphine; Enkephalin, D-Penicillamine (2,5)-; Fentanyl; Fluoresceins; Humans; Immunosuppression Therapy; K562 Cells; Killer Cells, Natural; Loperamide; Methadone; Morphinans; Morphine; Naloxone; Naltrexone; Succinimides; Toll-Like Receptor 4; Tramadol	2019
Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report. Substance abuse, 2019, Volume: 40, Issue:2 Topics: Adult; Antidiarrheals; Antiemetics; Antipruritics; Buprenorphine; Clonidine; Deprescriptions; Drug Substitution; Female; Humans; Loperamide; Methadone; Methocarbamol; Muscle Relaxants, Central; Naltrexone; Narcotic Antagonists; Ondansetron; Opiate Substitution Treatment; Opioid-Related Disorders; Promethazine; Substance Withdrawal Syndrome; Sympatholytics	2019
Loperamide Addiction: Atypical Opioid Use Disorder Treated With Buprenorphine/Naloxone. The primary care companion for CNS disorders, 2019, Jul-03, Volume: 21, Issue:4 Topics: Abuse-Deterrent Formulations; Adult; Analgesics, Opioid; Buprenorphine; Drug Therapy, Combination; Female; Humans; Loperamide; Naloxone; Narcotic Antagonists; Opioid-Related Disorders	2019
Long-term Buprenorphine Treatment for Loperamide Use Disorder: A Case Series. Journal of addiction medicine, 2020, Volume: 14, Issue:6 Topics: Analgesics, Opioid; Buprenorphine; Humans; Loperamide; Opioid-Related Disorders; Substance Withdrawal Syndrome; United States	2020
An Opioid Hiding in Plain Sight: Loperamide-Induced False-Positive Fentanyl and Buprenorphine Immunoassay Results. The journal of applied laboratory medicine, 2022, Oct-29, Volume: 7, Issue:6 Topics: Analgesics, Opioid; Buprenorphine; Fentanyl; Humans; Immunoassay; Loperamide	2022
Ventricular Arrhythmias Associated With Over-the-Counter and Recreational Opioids. Journal of the American College of Cardiology, 2023, 06-13, Volume: 81, Issue:23 Topics: Analgesics, Opioid; Arrhythmias, Cardiac; Buprenorphine; Diphenoxylate; Humans; Loperamide; Methadone; Naltrexone; Nonprescription Drugs	2023